Pharma Bio Ltd and Cell Therapies Pty Ltd have entered into a memorandum of understanding to establish an alliance that will provide our customers with a complete cell processing and delivery solution for the Asia Pacific Region.
The regenerative medicine and cellular therapy industries are growing rapidly and multiple later stage studies continue to demonstrate the potential to use human cells as therapeutic agents to address significant un-met medical needs.
High quality cell collection, processing and delivery infrastructure will be a key enabler for these therapies to move into clinical trials and then become standard of care. This capability is scarce today, particularly in the Asia Pacific region.
The alliance will provide the essential infrastructure as a “single point of access” solution for global companies seeking to take advantage of the large patient population and attractive regulatory pathways in this region.
Please click here for further details on the alliance.